Results 31 to 40 of about 5,338,575 (282)
Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease
Neurobiology of Disease, 2011 Cell adhesion molecules might play an important role in the inflammatory mechanisms associated with neurodegeneration. We have previously observed, in rats, that subcutaneous injection of complete Freund's adjuvant (CFA), a pro-inflammatory agent that ...
Marie-Therese Armentero +5 more
doaj +1 more source
Progress Notes : a report from the Parkinson's Disease Center at Boston University Medical Center [PDF]
, 1990 News and updates from the Boston University Medical Center Parkinson's Disease ...
Parkinson's Disease Center at Boston University Medical Center
core +2 more sources
Musculoskeletal Pain in Parkinson's Disease
Frontiers in Neurology, 2022 BackgroundMusculoskeletal pain is commonly experienced in patients with Parkinson's disease (PD). Few studies have investigated the clinical characteristics and risk factors associated with musculoskeletal pain.ObjectivesTo investigate the distribution ...
Jun Li +20 more
doaj +1 more source
Dopaminergic medication boosts action-effect binding in Parkinson's disease [PDF]
, 2010 Parkinson's disease (PD) is a neurodegenerative disorder affecting voluntary motor control. However, little is known about the experience of voluntary action in PD patients.
Bhatia, Kailash P. +5 more
core +1 more source
Frontiers in Aging NeuroscienceBackgroundThe standard therapy of Parkinson’s disease consists in supplementing the depleted dopamine with oral levodopa. The disadvantages of the levodopa monotherapy – comparable to other dopaminergic substances – are the dose-dependent development of ...
Christian Oehlwein +5 more
doaj +1 more source
Severe Constipation in Parkinson's Disease and in Parkinsonisms: Prevalence and Affecting Factors
Frontiers in Neurology, 2019 Background: constipation is one of the most common and disabling non-motor symptoms of Parkinson Disease (PD) and Parkinsonisms (PS). Few studies evaluate the difference of prevalence between PD and PS and the cause leading to a severe constipation in ...
Giuseppe Frazzitta +4 more
doaj +1 more source
Clinical Parkinsonism & Related Disorders, 2023 Dopamine agonists (DAs) have demonstrated efficacy for the treatment of Parkinson’s disease (PD) but are limited by adverse effects (AEs). DAs can vary considerably in their receptor subtype selectivity and affinity, chemical composition, receptor ...
Stuart H. Isaacson +4 more
doaj +1 more source
The frequency and validity of self-reported diagnosis of Parkinson's Disease in the UK elderly: MRC CFAS cohort [PDF]
, 2006 Background: Estimates of the incidence and prevalence of chronic diseases can be made using established cohort studies but these estimates may have lower reliability if based purely on self-reported diagnosis.Methods: The MRC Cognitive Function & Ageing ...
MRC CFAS, The +13 more
core +2 more sources
Understanding health care needs among Veterans with Parkinson's disease: A survey study
Frontiers in Neurology, 2022 Among Veterans, it is estimated that 110,000 are living with Parkinson's disease (PD) in the United States. Whether or not Veterans living with PD are enrolled in the Veterans Health Administration (VHA), they may require special considerations when it ...
Megan Feeney +9 more
doaj +1 more source
Progress Notes : a report from the Parkinson's Disease Center at Boston University Medical Center [PDF]
, 1989 News and updates from the Boston University Medical Center, Parkinson's Disease ...
Parkinson's Disease Center at Boston University Medical Center
core +1 more source